Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Interleukin
    (4)
  • IL Receptor
    (3)
  • CCR
    (2)
  • Src
    (2)
  • Apoptosis
    (1)
  • Transferase
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

eosinophilic asthma

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    9
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    3
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
Mepolizumab
SB 240563
T9962196078-29-2
Mepolizumab (SB 240563) is a humanized monoclonal antibody that neutralizes IL-5, and can be utilized in research on severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
  • $163
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Benralizumab
MEDI-563, BIW-8405
T104971044511-01-4
Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Rα). It enhances antibody-dependent cell-mediated cytotoxicity, leading to a rapid depletion of eosinophils. Benralizumab is used for severe eosinophilic asthma and can be employed to prevent exacerbations of chronic obstructive pulmonary disease.
  • $538
In Stock
Size
QTY